+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
MyoKardia Inc - logo

MyoKardia is a clinical stage biopharmaceutical company that develops therapies for the treatment of serious and neglected rare cardiovascular diseases. Its lead product candidate is MYK-461, a small molecule that is in three Phase I clinical trials designed to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy (HCM). MyoKardia, Inc. was founded in 2012 and is headquartered in South San Francisco, California.

Dilated Cardiomyopathy Therapeutic Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028) - Product Thumbnail Image

Dilated Cardiomyopathy Therapeutic Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023 - 2028)

  • Report
  • April 2023
  • 112 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2024

  • Report
  • April 2024
  • 300 Pages
  • Global
From
Dilated Cardiomyopathy Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Dilated Cardiomyopathy Therapeutics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 118 Pages
  • Global
From
Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • June 2022
  • 101 Pages
  • Global
From
Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Dilated Cardiomyopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • February 2022
  • 80 Pages
  • Global
From
Hypertrophic Cardiomyopathy (HCM) Therapeutics Global Market Report 2024 - Product Thumbnail Image

Hypertrophic Cardiomyopathy (HCM) Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Dilated Cardiomyopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Dilated Cardiomyopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Global Heart Failure Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025 - Product Thumbnail Image

Global Heart Failure Drugs Market – Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025

  • Report
  • April 2019
  • 88 Pages
  • Global
From
Licensing Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Licensing Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1300 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2019-2024 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2019-2024

  • Report
  • March 2024
  • 1000 Pages
  • Global
From
Hypertrophic Cardiomyopathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Hypertrophic Cardiomyopathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 102 Pages
  • Global
From
Dilated Cardiomyopathy Therapeutics Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Dilated Cardiomyopathy Therapeutics Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application

  • Report
  • May 2021
  • 81 Pages
  • Global
From
Atrial Fibrillation - Pipeline Review, H2 2020 - Product Thumbnail Image

Atrial Fibrillation - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 134 Pages
  • Global
From
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020 - Product Thumbnail Image

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 631 Pages
  • Global
From
Dilated Cardiomyopathy - Pipeline Review, H2 2020 - Product Thumbnail Image

Dilated Cardiomyopathy - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 66 Pages
  • Global
From
Continuous and Semi-Continuous Bioprocessing Market by Type of Manufacturer, Company Size, Scale of Operation, Stage of Bioprocess, Geographical Regions: Industry Trends and Global Forecasts, 2021-2030 - Product Thumbnail Image

Continuous and Semi-Continuous Bioprocessing Market by Type of Manufacturer, Company Size, Scale of Operation, Stage of Bioprocess, Geographical Regions: Industry Trends and Global Forecasts, 2021-2030

  • Report
  • June 2021
  • 191 Pages
  • Global
From
MyoKardia (MYOK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry - Product Thumbnail Image

MyoKardia (MYOK:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry

  • Company Profile
  • January 2020
  • 82 Pages
From
MyoKardia Inc - Strategic SWOT Analysis Review - Product Thumbnail Image

MyoKardia Inc - Strategic SWOT Analysis Review

  • SWOT Analysis
  • July 2021
  • 35 Pages
From
  • 18 Results (Page 1 of 1)
Loading Indicator